complexes, although the differences did not reach statistical significance, except for NDUFA9 (complex I) (Fig. 4d ).
← all excerpts
The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome.
2
—
—
The sentences
Prolonged treatment with BF demonstrated a tendency of increasing LV FS and LV EF values in 7-month-old WT mice as well, although the difference did not quite reach statistical significance.